Trial intelligence / Profile preview

Radiation, Brachytherapy, Cisplatin, and Amifostine in Cervical Cancer

NCT00012012Phase 2Completed

Sponsor
NRG Oncology
Start
Aug 2001
Primary completion
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of amifostine in acute radiation syndrome (ARS), sponsored by NRG Oncology. Started Aug 2001; status: completed.

02

Drugs

amifostine
03

Conditions

acute radiation syndrome (ARS)

Beyond the preview

Go deeper on NCT00012012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00012012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call